Stay updated on KN026 & KN046 Combo in Locally Advanced HER2+ Tumors Clinical Trial
Sign up to get notified when there's something new on the KN026 & KN046 Combo in Locally Advanced HER2+ Tumors Clinical Trial page.

Latest updates to the KN026 & KN046 Combo in Locally Advanced HER2+ Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the study history, indicating an update to the record. The previous revision 'Revision: v3.6.5' appears to be removed from the visible history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new version entry, Revision: v3.6.5, was added to the record history, replacing the previous Revision: v3.6.4. This reflects a minor update to the page's release/version metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedNew revision entry v3.6.4 has been added to the study record versions, while the previous revision v3.6.3 has been removed. This reflects an update to the page's release history for the trial record.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision tag v3.6.3 has been added to the study record history. The previous revision v3.6.2 has been removed from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe study record history now includes a new entry for Revision: v3.6.2 and removes the previous Revision: v3.6.0, reflecting an update to the platform's history-tracking version.SummaryDifference0.1%

- Check93 days agoChange DetectedIntroduces a recruitment status note indicating no longer looking for participants and records a new release version (Revision: v3.6.0), while removing the older release note (Revision: v3.5.5).SummaryDifference0.4%

Stay in the know with updates to KN026 & KN046 Combo in Locally Advanced HER2+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 & KN046 Combo in Locally Advanced HER2+ Tumors Clinical Trial page.